Carris Health LLC
Carris Health LLC was paid $8.27M by Medicaid between Jan 2018 and Dec 2024, across 106 billing codes. Its largest line is 99283, emergency room visit (moderate) — 36% of everything it billed.
WILLMAR, MN 56201
Next to other Rehabilitation Clinic/Center providers in Minnesota
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,392 | $461K | |
| 2019 | 21,039 | $1.47M | |
| 2020 | 21,359 | $1.19M | |
| 2021 | 26,129 | $1.57M | |
| 2022 | 21,758 | $1.38M | |
| 2023 | 19,436 | $1.28M | |
| 2024incomplete | 12,898 | $913K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 36% | 16,289 | 15,380 | $2.97M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 24% | 13,549 | 13,011 | $1.99M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 8.3% | 8,915 | 7,101 | $683K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 4.5% | 4,182 | 2,907 | $371K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.9% | 3,302 | 3,045 | $326K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.3% | 3,152 | 2,085 | $271K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.2% | 1,633 | 1,485 | $261K |
| 97597 | 2.6% | 1,548 | 741 | $211K | |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 1.8% | 726 | 635 | $145K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.7% | 1,256 | 1,222 | $145K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1.4% | 455 | 448 | $112K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,034 | 261 | $80K |
94 more codes
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 232 | $68K |
| A0425 | Ground mileage, per statute mile | <1% | 827 | $67K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,037 | $60K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,457 | $54K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,546 | $46K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,547 | $40K |
| 80053 | Comprehensive metabolic panel | <1% | 9,891 | $36K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 709 | $29K |
| 90837 | Psychotherapy session, about an hour | <1% | 161 | $28K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,827 | $27K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 179 | $20K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 53 | $17K |
| 86900 | <1% | 530 | $17K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 346 | $15K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 18,250 | $15K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,352 | $14K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,493 | $13K |
| 95811 | <1% | 13 | $12K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,929 | $11K |
| 36592 | <1% | 2,630 | $11K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 597 | $9K |
| 86850 | <1% | 511 | $8K | |
| 86901 | <1% | 530 | $7K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 247 | $6K |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,129 | $6K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 238 | $6K |
| G0475 | Hiv antigen/antibody, combination assay, screening | <1% | 274 | $5K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 42 | $5K |
| 99285 | Emergency room visit (most serious) | <1% | 13 | $4K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,828 | $4K |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 16 | $4K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 110 | $3K |
| 84145 | <1% | 686 | $3K | |
| 86803 | <1% | 263 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 422 | $3K |
| 85379 | <1% | 360 | $3K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 15 | $2K |
| 86480 | <1% | 37 | $2K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 12 | $2K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 12 | $2K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 152 | $2K |
| 81001 | <1% | 6,356 | $2K | |
| 87430 | <1% | 757 | $1K | |
| 83880 | <1% | 103 | $1K | |
| 86780 | <1% | 140 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 13 | $1K |
| 83690 | <1% | 1,655 | $884.90 | |
| 83605 | <1% | 681 | $878.02 | |
| 87070 | <1% | 56 | $843.39 | |
| 84484 | <1% | 1,249 | $833.41 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 51 | $743.11 |
| 87631 | <1% | 41 | $636.00 | |
| 80076 | <1% | 117 | $570.58 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 878 | $550.80 |
| 82607 | <1% | 37 | $541.55 | |
| 86704 | <1% | 36 | $433.30 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 36 | $397.28 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 15 | $387.83 |
| 86140 | <1% | 1,299 | $348.20 | |
| 36591 | <1% | 47 | $316.08 | |
| 82248 | <1% | 1,060 | $304.17 | |
| 87340 | <1% | 49 | $282.08 | |
| 87081 | <1% | 65 | $207.95 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 29 | $178.20 |
| 86706 | <1% | 16 | $171.68 | |
| 87040 | <1% | 20 | $157.75 | |
| 87077 | <1% | 14 | $152.61 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 93 | $138.64 |
| Q3014 | Telehealth originating site facility fee | <1% | 14 | $122.38 |
| 83735 | <1% | 490 | $111.01 | |
| 86762 | <1% | 29 | $106.50 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 74 | $96.22 |
| 82077 | <1% | 140 | $95.59 | |
| 82570 | <1% | 21 | $57.94 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 148 | $52.43 |
| 84450 | <1% | 37 | $41.44 | |
| 84460 | <1% | 37 | $37.11 | |
| 85730 | <1% | 52 | $30.60 | |
| 80143 | <1% | 15 | $26.97 | |
| J2704 | Injection, propofol, 10 mg | <1% | 12 | $25.65 |
| 85610 | <1% | 101 | $21.85 | |
| 85049 | <1% | 15 | $17.92 | |
| 80306 | <1% | 79 | $16.93 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 12 | $15.29 |
| 80179 | <1% | 15 | $13.49 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 14 | $12.83 |
| 82550 | <1% | 40 | $6.83 | |
| 82962 | <1% | 45 | $3.24 | |
| 82140 | 0% | 14 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 73 | $0.00 |
| 74019 | 0% | 16 | $0.00 | |
| 85652 | 0% | 15 | $0.00 | |
| 85027 | 0% | 26 | $0.00 | |
| 83615 | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| ST. Cloud Hospital | Saint Cloud, MN | $53.43M |
| Centracare Clinic | St Cloud, MN | $20.93M |
| Centracare Clinic | St Cloud, MN | $19.28M |
| Centracare Health System | Big Lake, MN | $12.82M |
| Carris Health LLC | Willmar, MN | $12.39M |
| Centracare Health Systems | Saint Cloud, MN | $9.41M |
| Centracare Health System | Saint Cloud, MN | $9.06M |
| Centracare Clinic | Saint Cloud, MN | $6.96M |
| Centracare Health System - Long Prairie | Long Prairie, MN | $6.86M |
| Centracare Health System-Nr LLC | Monticello, MN | $6.73M |
| Centracare Clinic | Sartell, MN | $6.11M |
| ST. Cloud Hospital | Saint Cloud, MN | $5.16M |
| Carris Health - Redwood LLC | Redwood Falls, MN | $4.74M |
| ST. Cloud Hospital | St Cloud, MN | $4.44M |
| Centracare Health System - Sauk Centre | Sauk Centre, MN | $4.19M |
| Centracare Health System - Melrose | Melrose, MN | $4.05M |
| Centracare Clinic | Saint Cloud, MN | $3.58M |
| Centracare Clinic | Saint Cloud, MN | $2.83M |
| Carris Health, LLC | Willmar, MN | $2.82M |
| ST. Cloud Hospital | Sauk Rapids, MN | $2.53M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.